CN105503888B - 一种盐酸纳洛酮晶型化合物 - Google Patents
一种盐酸纳洛酮晶型化合物 Download PDFInfo
- Publication number
- CN105503888B CN105503888B CN201610075580.XA CN201610075580A CN105503888B CN 105503888 B CN105503888 B CN 105503888B CN 201610075580 A CN201610075580 A CN 201610075580A CN 105503888 B CN105503888 B CN 105503888B
- Authority
- CN
- China
- Prior art keywords
- naloxone hydrochloride
- form compound
- solution
- naloxone
- hydrochloride crystal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
序号 | 衍射角2θ(度) | d值 | 相对强度(%) |
1 | 4.918 | 17.95421 | 27.1 |
2 | 6.481 | 13.62778 | 14.6 |
3 | 7.415 | 11.91332 | 11.8 |
4 | 8.08 | 10.93416 | 13.7 |
5 | 10.425 | 8.47907 | 11.9 |
6 | 12.937 | 6.83766 | 12.5 |
7 | 13.649 | 6.48265 | 5.1 |
8 | 14.922 | 5.93235 | 8.8 |
9 | 16.27 | 5.44351 | 4.5 |
10 | 17.216 | 5.14666 | 27.9 |
11 | 19.826 | 4.4746 | 100 |
12 | 21.219 | 4.18378 | 19.4 |
13 | 22.624 | 3.92706 | 22.5 |
14 | 23.471 | 3.78722 | 10.3 |
15 | 25.5 | 3.49029 | 27 |
16 | 26.153 | 3.40465 | 8.9 |
17 | 26.701 | 3.33599 | 8.2 |
18 | 30.549 | 2.92397 | 4.2 |
19 | 31.378 | 2.84854 | 5.2 |
20 | 32.203 | 2.7775 | 3.1 |
21 | 32.817 | 2.72692 | 5.8 |
22 | 37.64 | 2.38779 | 2.6 |
实施例1 | 实施例2 | 实施例3 | 实施例4 | 对比例1 | 对比例2 | |
溶解度 | 37.9mg/ml | 36.5mg/ml | 37.6 mg/ml | 38.3 mg/ml | 37.1 mg/ml | 34.9 mg/ml |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610075580.XA CN105503888B (zh) | 2016-02-03 | 2016-02-03 | 一种盐酸纳洛酮晶型化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610075580.XA CN105503888B (zh) | 2016-02-03 | 2016-02-03 | 一种盐酸纳洛酮晶型化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105503888A CN105503888A (zh) | 2016-04-20 |
CN105503888B true CN105503888B (zh) | 2016-07-06 |
Family
ID=55712248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610075580.XA Active CN105503888B (zh) | 2016-02-03 | 2016-02-03 | 一种盐酸纳洛酮晶型化合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105503888B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023168502A1 (pt) * | 2022-03-08 | 2023-09-14 | Eurofarma Laboratórios S.A. | Forma cristalina anidra t de cloridrato de naloxona e seu processo de obtenção |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811547A (en) * | 1992-10-14 | 1998-09-22 | Nippon Shinyaju Co., Ltd. | Method for inducing crystalline state transition in medicinal substance |
CN101590014A (zh) * | 2009-06-24 | 2009-12-02 | 山东新华制药股份有限公司 | 盐酸纳洛酮注射液制备工艺 |
CN103304570A (zh) * | 2013-07-12 | 2013-09-18 | 四川省惠达药业有限公司 | 一种盐酸纳洛酮化合物、其制备方法及其药物组合物 |
-
2016
- 2016-02-03 CN CN201610075580.XA patent/CN105503888B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811547A (en) * | 1992-10-14 | 1998-09-22 | Nippon Shinyaju Co., Ltd. | Method for inducing crystalline state transition in medicinal substance |
CN101590014A (zh) * | 2009-06-24 | 2009-12-02 | 山东新华制药股份有限公司 | 盐酸纳洛酮注射液制备工艺 |
CN103304570A (zh) * | 2013-07-12 | 2013-09-18 | 四川省惠达药业有限公司 | 一种盐酸纳洛酮化合物、其制备方法及其药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN105503888A (zh) | 2016-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103735500B (zh) | 盐酸他喷他多注射液及其制备方法 | |
CN103396328B (zh) | 盐酸甲氯芬酯化合物及其药物组合物 | |
CN105503888B (zh) | 一种盐酸纳洛酮晶型化合物 | |
MX2012010952A (es) | Forma cristalina de citrato de aldefanil, metodo de preparacion y uso del mismo. | |
CN102266343A (zh) | 供注射用盐酸法舒地尔药物组合物 | |
KR20200003791A (ko) | 듀테트라베나진의 유사체, 이의 제조 및 용도 | |
CN102166185B (zh) | 等渗纳洛酮注射液及其制备方法 | |
WO2009093206A2 (ru) | 3-CУЛЬФOHИЛ-ПИPAЗOЛO[1,5-a]ПИPИMИДИHЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ | |
CN103906757A (zh) | 盐酸伊达比星的结晶 | |
CN104086531B (zh) | 一种埃索美拉唑钠化合物及其药物组合物 | |
US8927572B2 (en) | Crystal form I of salt of a dipeptidyl peptidase-IV inhibitor and preparation method and use thereof | |
CN103027890B (zh) | 供注射用的布洛芬药物组合物 | |
CN103655460B (zh) | 一种含氨曲南的注射用药物组合物及其制备方法和用途 | |
CN113398065A (zh) | 一种间苯三酚注射液的制备方法 | |
CN102552210B (zh) | 一种恩替卡韦胶囊组合物及其制备方法 | |
CN104370792B (zh) | 奥拉西坦化合物 | |
CN102274194A (zh) | 一种含托烷司琼化合物的药物组合物及其制备方法 | |
RU2407738C1 (ru) | Противовирусный активный компонент, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний | |
CN106267148A (zh) | 一种醋酸阿托西班组合物及其制备方法 | |
CN107303266B (zh) | 左旋奥拉西坦注射液及其制备方法 | |
CN105541946A (zh) | 一种环磷腺苷晶型化合物 | |
CN106943344B (zh) | 一种稳定性好的(s)-4-羟基-2氧代-1-吡咯烷乙酰胺注射剂及其制备方法 | |
CN101078715B (zh) | 一种标准品溶液及其配制方法和应用 | |
CN107432864A (zh) | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺无菌粉末及其制备方法 | |
CN111166715A (zh) | 一种格隆溴铵注射剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160420 Assignee: Shanxi Powerdone Pharmaceutics Co., Ltd. Assignor: Guo Kun Contract record no.: 2017990000047 Denomination of invention: Naloxone hydrochloride crystal form compound Granted publication date: 20160706 License type: Exclusive License Record date: 20170203 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180802 Address after: 450003 No. 39 building, 90 Zhenghua Road, Jinshui District, Zhengzhou, Henan 13 Patentee after: Yan Hulin Address before: 471000 No. 4, Mangshan Road, Hui He District, Luoyang, Henan Patentee before: Guo Kun |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220425 Address after: 450000 No. 1, northeast corner of Huihuang 4th Road, Shenhou Road, Guandu town, Zhongmou County, Zhengzhou City, Henan Province Patentee after: Sihuan Pharmaceutical (Zhengzhou) Co.,Ltd. Address before: 450003 No. 39 building, 90 Zhenghua Road, Jinshui District, Zhengzhou, Henan 13 Patentee before: Yan Hulin |
|
TR01 | Transfer of patent right |